Abstract
Background and Aims : Angiopoietin-like 3 (ANGPTL3) is an inhibitor of lipoprotein lipase (LPL) and endothelial lipase (EL). The impact of ANGPTL3 lowering has been shown to depend on the type of dyslipidemia: reduced LDL cholesterol in patients with familial hypercholesterolemia and reductions in plasma triglycerides in patients with chylomicronemia. This differential effect may be related to a difference in the association of ANGPTL3 with lipoproteins. We therefore hypothesized that ANGPTL3 resides on lipoproteins and that this affects its ability to suppress lipase activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.